Por: ABC News Business May 09, 2023
Novavax is cutting about a quarter of its global workforce as the COVID-19 vaccine maker seeks to slash expenses while dealing with uncertain future revenue.The company said Tuesday that it expects to trim next year’s costs for research and development as well as selling, general and administrative expenses by about 40% to 50% compared to 2022. The company has 1,992 full-time employees. A Novavax representative said the cuts will affect about... + full article
Associated Press USA Business May 09, 2023
Novavax is cutting about a quarter of its global workforce as the COVID-19 vaccine maker seeks to slash expenses while dealing with uncertain future revenue.The company said Tuesday that it expects to trim next year’s costs for research and development as well as selling,... + más
FDA Authorizes Novavax's Covid Shots as Mix-And-Match Booster to Pfizer Or Moderna | NBC 6 South Florida
COVID-19 vaccine maker Novavax to chop workforce, expenses | ABC News
Fox Business USA Business May 09, 2023
DoubleLine Deputy CIO Jeffrey Sherman predicts that the Fed will 'hike' rates to avoid 'upsetting the market.' Vaccine maker Novavax announced Tuesday that it's by 25% in an effort to significantly cut down on expenses and shift its focus to key... + más
FDA authorizes Novavax's Covid shots as mix-and-match booster to Pfizer or Moderna | CNBC
Forbes USA Tech October 22, 2022
The U.S. Food and Drug Administration (FDA) has just extended the emergency use authorization (EUA) ... [+] for Novavax’s adjuvanted (NVX-CoV2373) Covid-19 vaccine to now include a first booster dose for those 18 years and older. (Photo by Matt McClain/The Washington Post via... + más
Los Angeles Times USA Science October 20, 2022
U.S. regulators on Wednesday authorized a booster dose of the COVID-19 vaccine made by Novavax. The Food and Drug Administration said the new booster option is for people 18 and older who can’t get the Omicron-targeting boosters from Pfizer-BioNTech or Moderna for medical or... + más
CNBC USA Health October 19, 2022
In this articleA healthcare worker prepares a dose of the Novavax Covid-19 vaccine at a pharmacy in Schwenksville, Pennsylvania, US, on Monday, Aug. 1, 2022.Hannah Beier Bloomberg Getty ImagesThe Food and Drug Administration has authorized 's Covid boosters for adults in... + más
Moderna vs. Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | PennLive
CNN USA Health October 19, 2022
CNN — The US Food and Drug Administration on Wednesday among adults 18 and older, at least six months after completing a primary Covid-19 vaccine series. The company announced that it has received emergency use authorization to provide a first booster dose of its vaccine... + más
US clears Novavax COVID booster dose | ABC News
NBC 6 South Florida USA World October 19, 2022
Hannah Beier Bloomberg Getty Images The Food and Drug Administration has authorized 's Covid boosters for adults in the U.S., including for people who received Pfizer's or Moderna's shots as their primary series. The authorization of Novavax's booster could... + más
About iurex | Privacy Policy | Disclaimer |